Effects of Osteopathic Manipulative Treatment in Chronic Non-allergic Rhinosinusitis
NCT ID: NCT04420052
Last Updated: 2023-08-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2021-07-01
2022-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods:
A sample of 90 patients diagnosed by ENT specialist will be randomly assigned to the OMT group or the placebo group. The placebo procedure will consist in using light touch around the nose, on the throat and on the thorax. Treatment and placebo protocols are composed of two visits at day 0 and day 30.
A general practitioner will determine the eligibility for the study.
The outcomes include Peak Nasal Inspiratory Flow (PNIF) measured five times: at day 0, 30 (twice each, before and after treatment) and 180 (once). The two groups will be compared regarding short and long term evolution.
The evolution of symptoms will be assessed by the Sino-nasal Outcome Test (SNOT-22) seven times: at day 0, 30, 60, 90, 120, 150 and 180. This outcome will be analyzed using mixed effect modelling
A Qualitative study will be conducted in the two groups to understand the patients' experiences during care.
This protocol has been approved by a french ethic committee (Comité de Protection des Personnes Sud Ouest et Outre-Mer II, 2020.04.09).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Facial Effleurage on Acute Rhinosinusitis
NCT04642989
Comparative Effects of Therapeutic Ultrasound and Sinus Massage in Chronic Rhinosinusitis: a Randomized Controlled Study
NCT06960876
Efficacy Of Erythromycin Phonophoresis on Chronic Rhinosinusitis
NCT07063082
Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps
NCT06850805
Medical Therapy Versus Sinus Surgery for Chronic Rhinosinusitis: A Prospective, Multi-institutional Study
NCT01255566
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
PNIF middle term evolution:
If the two groups can be compared regarding their socio-demographics characteristics, a student's t-test will compare evolution (day 0 before treatment to day 30 before treatment) of the PNIF between groups.
If characteristics are different, a multivariate linear model will be applied.
PNIF long term evolution:
The same tests will be made. The evolution will be assessed between day 0 (before treatment) and day 180.
PNIF short term evolution:
The same tests will be made. The evolution will be assessed before and after treatment at day 0 and day 30.
SNOT-22 evolution:
Mixed effect model will assess the evolution of symptoms from day 0 to day 180
Response Shift detection:
For the SNOT-22, an Oort procedure will be performed in order to detect Response shift among individuals.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
OMT group
Osteopathic manipulative treatment
Osteopaths will executed several high velocity low amplitude (HVLA) techniques on the upper thoracic spine and cervical spine. These techniques are assumed to modulate the sympathetic cervical ganglia and reduce inflammation in chronic rhinosinusitis.
This procedure takes around 15 minutes.
Placebo group
Placebo manipulation
The osteopath will lay hands without movement on the nose, the throat and the thorax of patients.
This procedure takes around 15 minutes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Osteopathic manipulative treatment
Osteopaths will executed several high velocity low amplitude (HVLA) techniques on the upper thoracic spine and cervical spine. These techniques are assumed to modulate the sympathetic cervical ganglia and reduce inflammation in chronic rhinosinusitis.
This procedure takes around 15 minutes.
Placebo manipulation
The osteopath will lay hands without movement on the nose, the throat and the thorax of patients.
This procedure takes around 15 minutes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Chronic rhinosinusitis diagnosed by ear, nose, and throat (ENT) specialist or general practitioner
* informed consent given
* registered under french social security system
Exclusion Criteria
* receiving other treatment for CRS during this study
* being pregnant
* being under legal protection
* withdrawal of consent
18 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut des Hautes Etudes Osteopathiques de Nantes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
sebastien cambier
Role: PRINCIPAL_INVESTIGATOR
Institut des Hautes Etudes Osteopathiques de Nantes
maxime salmon, MsC
Role: STUDY_DIRECTOR
Institut des Hautes Etudes Osteopathiques de Nantes
Marie Moreau
Role: STUDY_CHAIR
Institut des Hautes Etudes Osteopathiques de Nantes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cabinet ORL du Maine
Le Mans, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-A02907-50
Identifier Type: OTHER
Identifier Source: secondary_id
Osteonose
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.